Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Sanofi lung cancer drug fails in late-stage trial

March 11, 2011 Research and Development Cancer, NSCLC, Regeneron, Sanofi-Aventis, aflibercept, non-small cell lung cancer

Sanofi-Aventis’ lung cancer drug aflibercept has failed to meet its primary endpoint in a phase III trial. The late-stage VITAL …
News

Tangles and plaques: unlocking the secrets of Alzheimer’s disease

March 11, 2011 Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, bapineuzumab, dimebon, latrepirdine, solanezumab

Despite many years of relentless research efforts, Alzheimer’s disease, the most common form of dementia, remains impossible to cure. According …
Feature

‘This R&D Malarkey, it’s broken, isn’t it?’

March 9, 2011 Research and Development R&D, Sandwich, research productivity

Pharmaceutical industry leaders are increasingly admitting that the very low productivity of its R&D pipelines is unsustainable – but no …
Feature

Francois Meyer to head up TxCell

March 9, 2011 Research and Development Francois Meyer, TxCell, appointment, research and development

French biotech TxCell has appointed François Meyer as chief executive. He has more than 25 years of pharma and biotech …
Appointment
AstraZeneca

AZ partners with Galderma on psoriasis research

March 9, 2011 Research and Development AZ, AstraZeneca, Galderma, dermatology, psoriasis

AstraZeneca has signed a five-year deal with dermatology specialist Galderma Pharma to develop new treatments for conditions including psoriasis. It …
News

Eisai confirms 20% cut in US workforce

March 8, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Aricept, Eisai, Halaven, US, donepezil, eribulin, pharma job cuts

Eisai’s planned job cuts will fall heaviest on its US operations, where 20% of the workforce will be let go …
News
Merck & Co workers protest job cuts

Merck says sale of Oss facility would be too expensive

March 8, 2011 Manufacturing and Production, Research and Development Holland, Merck & Co, Oss, Oss pharma research, Pantarhei Bioscience

The debate around the closure of Merck & Co’s R&D and manufacturing unit in Oss, the Netherlands, rumbles on, with …
News

Ethical practices – pharma’s obligation

March 8, 2011 Research and Development, Sales and Marketing ethics, industry relations, industry reputation

Pharmaceutical companies are not charities, and neither is any other business, by definition. Capitalism as a recognised system has been …
Feature
GlaxoSmithKline's London headquarters

GSK ends neuroscience research alliance

March 7, 2011 Research and Development GSK, GlaxoSmithKline, Targacept, neuronal nicotinic receptors, neuroscience research

GlaxoSmithKline has severed a strategic alliance formed in July 2007 with US biopharma company Targacept. GSK forked out $45 million …
News

Government injects £775m into NHS translational research

March 7, 2011 Research and Development ABPI, Kent, NHS research, Pfizer research Kent, Sandwich, Science and Technology Select Committee, translational research

The government has pledged around £775 million for translational research, saying it will help modernise the health service and support …
News
Novo Nordisk's Victoza

Novo’s Victoza beats Bydureon in head-to-head trial

March 4, 2011 Research and Development, Sales and Marketing Alkermes, Amylin, Byureon, Victoza, diabetes, exenatide, lilly, type II diabetes

Bydureon has been outperformed by rival Victoza in a head-to-trial, decimating shares in its co-developer Amylin and Alkermes, the company …
News
Science minister David Willetts

Universities to ‘pick up pharma’s R&D mantle’ after Pfizer closure

March 3, 2011 Research and Development Kent, Pfizer, Sandwich, Science and Technology Select Committee, UK research, UK science, job cuts

Science in the UK will have to focus on contractually-based research in the future as pharma’s R&D presence in the …
News
GlaxoSmithKline's London headquarters

GSK to reimburse tuition fees for UK trainees

March 3, 2011 Business Services, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, UK science, careers, graduate, graduate recruitment

GlaxoSmithKline is set to reimburse UK university tuition fees paid by its trainees from 2012. Each year, GSK recruits between …
News
The RNA interference process

RNA interference – still the great white hope?

March 3, 2011 Manufacturing and Production, Research and Development RNA interference, rnai

The emerging field of RNA interference – also known as ‘gene silencing’ – is one of the most promising in …
Feature

UCB teams up with Harvard for CNS research

March 2, 2011 Research and Development CNS, Harvard, UCB, academia, academic research, immunology

UCB has signed a new research collaboration with Harvard University that will focus on central nervous system and immunology therapies. …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026